EP2061748A2 - Synthèse asymétrique catalytique d'amines primaires par réduction au borane d'éthers d'oxime au moyen d'esters de spiroborate - Google Patents
Synthèse asymétrique catalytique d'amines primaires par réduction au borane d'éthers d'oxime au moyen d'esters de spiroborateInfo
- Publication number
- EP2061748A2 EP2061748A2 EP07814214A EP07814214A EP2061748A2 EP 2061748 A2 EP2061748 A2 EP 2061748A2 EP 07814214 A EP07814214 A EP 07814214A EP 07814214 A EP07814214 A EP 07814214A EP 2061748 A2 EP2061748 A2 EP 2061748A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- chiral
- oxime
- reduction
- prochiral
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000009467 reduction Effects 0.000 title claims abstract description 57
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 title claims abstract description 56
- -1 oxime ethers Chemical class 0.000 title claims abstract description 39
- 229910000085 borane Inorganic materials 0.000 title claims abstract description 29
- 150000003141 primary amines Chemical class 0.000 title claims abstract description 16
- 150000002148 esters Chemical class 0.000 title description 16
- 230000003197 catalytic effect Effects 0.000 title description 14
- 238000011914 asymmetric synthesis Methods 0.000 title description 4
- 238000000034 method Methods 0.000 claims abstract description 56
- 238000006243 chemical reaction Methods 0.000 claims abstract description 44
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 29
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract 8
- 230000008569 process Effects 0.000 claims description 42
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 40
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 32
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 claims description 23
- 239000002904 solvent Substances 0.000 claims description 21
- 150000001875 compounds Chemical class 0.000 claims description 19
- 239000000243 solution Substances 0.000 claims description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 16
- 239000003153 chemical reaction reagent Substances 0.000 claims description 16
- 150000001412 amines Chemical class 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 9
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 239000012074 organic phase Substances 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims 3
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 125000000547 substituted alkyl group Chemical group 0.000 claims 2
- 150000007513 acids Chemical class 0.000 claims 1
- 150000007514 bases Chemical class 0.000 claims 1
- 239000003637 basic solution Substances 0.000 claims 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 239000002274 desiccant Substances 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 239000003054 catalyst Substances 0.000 abstract description 48
- 150000002923 oximes Chemical class 0.000 abstract description 10
- 150000000179 1,2-aminoalcohols Chemical class 0.000 abstract description 5
- 238000005457 optimization Methods 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 3
- 125000001743 benzylic group Chemical group 0.000 abstract description 2
- 235000010290 biphenyl Nutrition 0.000 abstract 1
- 239000004305 biphenyl Substances 0.000 abstract 1
- 125000003544 oxime group Chemical group 0.000 abstract 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 66
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 66
- 238000006722 reduction reaction Methods 0.000 description 53
- UHOVQNZJYSORNB-MZWXYZOWSA-N benzene-d6 Chemical compound [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1[2H] UHOVQNZJYSORNB-MZWXYZOWSA-N 0.000 description 40
- 238000005160 1H NMR spectroscopy Methods 0.000 description 37
- 238000004440 column chromatography Methods 0.000 description 35
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 27
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 27
- 238000005356 chiral GC Methods 0.000 description 22
- 229940052303 ethers for general anesthesia Drugs 0.000 description 22
- 229940093499 ethyl acetate Drugs 0.000 description 22
- 235000019439 ethyl acetate Nutrition 0.000 description 22
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 21
- 239000000499 gel Substances 0.000 description 21
- 229910052710 silicon Inorganic materials 0.000 description 21
- 239000010703 silicon Substances 0.000 description 21
- 239000007787 solid Substances 0.000 description 18
- 238000004458 analytical method Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- SQDFHQJTAWCFIB-UHFFFAOYSA-N n-methylidenehydroxylamine Chemical compound ON=C SQDFHQJTAWCFIB-UHFFFAOYSA-N 0.000 description 10
- 239000000741 silica gel Substances 0.000 description 10
- 229910002027 silica gel Inorganic materials 0.000 description 10
- 239000012230 colorless oil Substances 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 8
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 7
- 238000004817 gas chromatography Methods 0.000 description 7
- LNQVZZGGOZBOQS-INIZCTEOSA-N (2s)-2-amino-3-methyl-1,1-diphenylbutan-1-ol Chemical compound C=1C=CC=CC=1C(O)([C@@H](N)C(C)C)C1=CC=CC=C1 LNQVZZGGOZBOQS-INIZCTEOSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 239000012279 sodium borohydride Substances 0.000 description 6
- 229910000033 sodium borohydride Inorganic materials 0.000 description 6
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- RQEUFEKYXDPUSK-UHFFFAOYSA-N 1-phenylethylamine Chemical compound CC(N)C1=CC=CC=C1 RQEUFEKYXDPUSK-UHFFFAOYSA-N 0.000 description 4
- 239000000935 antidepressant agent Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 4
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000007832 Na2SO4 Substances 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000003869 acetamides Chemical class 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 229940125904 compound 1 Drugs 0.000 description 3
- 229940126214 compound 3 Drugs 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- VLMRVPGKOPABPT-JTQLQIEISA-N n-[(1s)-1-pyridin-3-ylpropyl]acetamide Chemical compound CC(=O)N[C@@H](CC)C1=CC=CN=C1 VLMRVPGKOPABPT-JTQLQIEISA-N 0.000 description 3
- BDOLXPFAFMNDOK-UHFFFAOYSA-N oxazaborolidine Chemical class B1CCON1 BDOLXPFAFMNDOK-UHFFFAOYSA-N 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- YDGRXDZZYIEJCG-SFQUDFHCSA-N (e)-1-(6-methoxypyridin-3-yl)-n-phenylmethoxyethanimine Chemical compound C1=NC(OC)=CC=C1C(\C)=N\OCC1=CC=CC=C1 YDGRXDZZYIEJCG-SFQUDFHCSA-N 0.000 description 2
- MIDMIXGYBIKXMO-DTQAZKPQSA-N (e)-1-phenyl-n-phenylmethoxyethanimine Chemical compound C=1C=CC=CC=1C(/C)=N/OCC1=CC=CC=C1 MIDMIXGYBIKXMO-DTQAZKPQSA-N 0.000 description 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- YLEIFZAVNWDOBM-ZTNXSLBXSA-N ac1l9hc7 Chemical compound C([C@H]12)C[C@@H](C([C@@H](O)CC3)(C)C)[C@@]43C[C@@]14CC[C@@]1(C)[C@@]2(C)C[C@@H]2O[C@]3(O)[C@H](O)C(C)(C)O[C@@H]3[C@@H](C)[C@H]12 YLEIFZAVNWDOBM-ZTNXSLBXSA-N 0.000 description 2
- 150000001414 amino alcohols Chemical class 0.000 description 2
- 230000001430 anti-depressive effect Effects 0.000 description 2
- 229940005513 antidepressants Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- JHNRZXQVBKRYKN-UHFFFAOYSA-N n-(1-phenylethylidene)hydroxylamine Chemical class ON=C(C)C1=CC=CC=C1 JHNRZXQVBKRYKN-UHFFFAOYSA-N 0.000 description 2
- CETUEEQZMGKICA-ZETCQYMHSA-N n-[(1s)-1-pyridin-2-ylethyl]acetamide Chemical compound CC(=O)N[C@@H](C)C1=CC=CC=N1 CETUEEQZMGKICA-ZETCQYMHSA-N 0.000 description 2
- LFQSOIIQWSNRLW-ZETCQYMHSA-N n-[(1s)-1-pyridin-3-ylethyl]acetamide Chemical compound CC(=O)N[C@@H](C)C1=CC=CN=C1 LFQSOIIQWSNRLW-ZETCQYMHSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- LALRXNPLTWZJIJ-UHFFFAOYSA-N triethylborane Chemical compound CCB(CC)CC LALRXNPLTWZJIJ-UHFFFAOYSA-N 0.000 description 2
- NHDIQVFFNDKAQU-UHFFFAOYSA-N tripropan-2-yl borate Chemical compound CC(C)OB(OC(C)C)OC(C)C NHDIQVFFNDKAQU-UHFFFAOYSA-N 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- RQEUFEKYXDPUSK-ZETCQYMHSA-N (1S)-1-phenylethanamine Chemical compound C[C@H](N)C1=CC=CC=C1 RQEUFEKYXDPUSK-ZETCQYMHSA-N 0.000 description 1
- ADXGZQRJIYRSGK-JTQLQIEISA-N (1s)-2-phenyl-1-(1,3-thiazol-2-yl)ethanamine Chemical compound C([C@H](N)C=1SC=CN=1)C1=CC=CC=C1 ADXGZQRJIYRSGK-JTQLQIEISA-N 0.000 description 1
- ZQNFUXDRYQQYAQ-IBGZPJMESA-N (2s)-2-amino-1,1,2-triphenylethanol Chemical compound C1([C@H](N)C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)=CC=CC=C1 ZQNFUXDRYQQYAQ-IBGZPJMESA-N 0.000 description 1
- PPTXVXKCQZKFBN-UHFFFAOYSA-N (S)-(-)-1,1'-Bi-2-naphthol Chemical compound C1=CC=C2C(C3=C4C=CC=CC4=CC=C3O)=C(O)C=CC2=C1 PPTXVXKCQZKFBN-UHFFFAOYSA-N 0.000 description 1
- FRRKMGKUCIICOM-CSKARUKUSA-N (e)-n-methoxy-1-phenylethanimine Chemical compound CO\N=C(/C)C1=CC=CC=C1 FRRKMGKUCIICOM-CSKARUKUSA-N 0.000 description 1
- JHNRZXQVBKRYKN-VQHVLOKHSA-N (ne)-n-(1-phenylethylidene)hydroxylamine Chemical compound O\N=C(/C)C1=CC=CC=C1 JHNRZXQVBKRYKN-VQHVLOKHSA-N 0.000 description 1
- HXBMIQJOSHZCFX-UHFFFAOYSA-N 1-(bromomethyl)-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1CBr HXBMIQJOSHZCFX-UHFFFAOYSA-N 0.000 description 1
- IKSNDOVDVVPSMA-UHFFFAOYSA-N 1-(bromomethyl)-4-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=C(CBr)C=C1 IKSNDOVDVVPSMA-UHFFFAOYSA-N 0.000 description 1
- MOHYOXXOKFQHDC-UHFFFAOYSA-N 1-(chloromethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CCl)C=C1 MOHYOXXOKFQHDC-UHFFFAOYSA-N 0.000 description 1
- HDXFCPZKMFTOLH-UHFFFAOYSA-N 1-amino-2,3-dihydroinden-1-ol Chemical compound C1=CC=C2C(N)(O)CCC2=C1 HDXFCPZKMFTOLH-UHFFFAOYSA-N 0.000 description 1
- MIDMIXGYBIKXMO-UHFFFAOYSA-N 1-phenyl-n-phenylmethoxyethanimine Chemical class C=1C=CC=CC=1C(C)=NOCC1=CC=CC=C1 MIDMIXGYBIKXMO-UHFFFAOYSA-N 0.000 description 1
- NWYYWIJOWOLJNR-UHFFFAOYSA-N 2-Amino-3-methyl-1-butanol Chemical compound CC(C)C(N)CO NWYYWIJOWOLJNR-UHFFFAOYSA-N 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- JHUUPUMBZGWODW-UHFFFAOYSA-N 3,6-dihydro-1,2-dioxine Chemical compound C1OOCC=C1 JHUUPUMBZGWODW-UHFFFAOYSA-N 0.000 description 1
- SPHAWXCQQFPLSS-UHFFFAOYSA-N 3-phenyl-2,3-dihydro-1h-inden-1-amine Chemical class C12=CC=CC=C2C(N)CC1C1=CC=CC=C1 SPHAWXCQQFPLSS-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- HIHOEGPXVVKJPP-JTQLQIEISA-N 5-fluoro-2-[[(1s)-1-(5-fluoropyridin-2-yl)ethyl]amino]-6-[(5-methyl-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile Chemical compound N([C@@H](C)C=1N=CC(F)=CC=1)C(C(=CC=1F)C#N)=NC=1NC=1C=C(C)NN=1 HIHOEGPXVVKJPP-JTQLQIEISA-N 0.000 description 1
- FVQDOKQWEOZEBQ-UHFFFAOYSA-N B1NCCO1 Chemical class B1NCCO1 FVQDOKQWEOZEBQ-UHFFFAOYSA-N 0.000 description 1
- OFDNQWIFNXBECV-UHFFFAOYSA-N Dolastatin 10 Natural products CC(C)C(N(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(C(C)CC)C(OC)CC(=O)N1CCCC1C(OC)C(C)C(=O)NC(C=1SC=CN=1)CC1=CC=CC=C1 OFDNQWIFNXBECV-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- WGQKYBSKWIADBV-UHFFFAOYSA-N aminomethyl benzene Natural products NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 150000008365 aromatic ketones Chemical class 0.000 description 1
- 238000007080 aromatic substitution reaction Methods 0.000 description 1
- 150000003975 aryl alkyl amines Chemical class 0.000 description 1
- DLGYNVMUCSTYDQ-UHFFFAOYSA-N azane;pyridine Chemical compound N.C1=CC=NC=C1 DLGYNVMUCSTYDQ-UHFFFAOYSA-N 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical compound [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 229960004132 diethyl ether Drugs 0.000 description 1
- OGCGXUGBDJGFFY-INIZCTEOSA-N diphenyl-[(2s)-pyrrolidin-2-yl]methanol Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(O)[C@@H]1CCCN1 OGCGXUGBDJGFFY-INIZCTEOSA-N 0.000 description 1
- OFDNQWIFNXBECV-VFSYNPLYSA-N dolastatin 10 Chemical compound CC(C)[C@H](N(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)[C@H](OC)CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C=1SC=CN=1)CC1=CC=CC=C1 OFDNQWIFNXBECV-VFSYNPLYSA-N 0.000 description 1
- 108010045524 dolastatin 10 Proteins 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 230000028270 inhibition of dopamine uptake Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- BHFLUDRTVIDDOR-QMMMGPOBSA-N methyl (2s)-2-amino-2-phenylacetate Chemical compound COC(=O)[C@@H](N)C1=CC=CC=C1 BHFLUDRTVIDDOR-QMMMGPOBSA-N 0.000 description 1
- CEMZBWPSKYISTN-YFKPBYRVSA-N methyl (2s)-2-amino-3-methylbutanoate Chemical compound COC(=O)[C@@H](N)C(C)C CEMZBWPSKYISTN-YFKPBYRVSA-N 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical compound [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- DVFCCGIRAKJTCE-JTQLQIEISA-N n-[(1s)-1-pyridin-4-ylpropyl]acetamide Chemical compound CC(=O)N[C@@H](CC)C1=CC=NC=C1 DVFCCGIRAKJTCE-JTQLQIEISA-N 0.000 description 1
- COCAUCFPFHUGAA-MGNBDDOMSA-N n-[3-[(1s,7s)-5-amino-4-thia-6-azabicyclo[5.1.0]oct-5-en-7-yl]-4-fluorophenyl]-5-chloropyridine-2-carboxamide Chemical compound C=1C=C(F)C([C@@]23N=C(SCC[C@@H]2C3)N)=CC=1NC(=O)C1=CC=C(Cl)C=N1 COCAUCFPFHUGAA-MGNBDDOMSA-N 0.000 description 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
- VEAYHPHBOCKIGG-UHFFFAOYSA-N n-phenylmethoxy-1-pyridin-4-ylethanimine Chemical compound C=1C=NC=CC=1C(C)=NOCC1=CC=CC=C1 VEAYHPHBOCKIGG-UHFFFAOYSA-N 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 230000012154 norepinephrine uptake Effects 0.000 description 1
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000013275 serotonin uptake Effects 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/30—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds
- C07C209/40—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of nitrogen-to-oxygen or nitrogen-to-nitrogen bonds by reduction of hydroxylamino or oxyimino groups
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/02—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
- B01J31/12—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing organo-metallic compounds or metal hydrides
- B01J31/14—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing organo-metallic compounds or metal hydrides of aluminium or boron
- B01J31/146—Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing organo-metallic compounds or metal hydrides of aluminium or boron of boron
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B53/00—Asymmetric syntheses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/60—Reduction reactions, e.g. hydrogenation
- B01J2231/64—Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
- B01J2231/641—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
- B01J2231/643—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of R2C=O or R2C=NR (R= C, H)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Definitions
- the claimed invention was made with U.S. Government support under grant numbers MBRS GM 08216 and NIH-IMBRE NC P20 RR-016470 awarded by the National Institutes of Health (NIH). The government has certain rights in this invention.
- the present invention relates to a method for the reduction of oxime ethers using stable spiroborate esters to prepare enantiopure primary amines in a truly catalytic process with excellent enantioselectivity.
- O-benzyloxy amine 2a can also, be obtained due to incomplete reduction.
- O-methylarylalkyl oxime ethers have been reduced with spiroborate esters derived from (S) proline and [R)- or (S)-1 ,1 '-bi-2-naphthol.
- Reduction of acetophenone O-methyloxime, as a model compound, with 2 equiv of borane and 10% of catalyst produced only 58% yield and 42% ee. Therefore, one equiv of catalyst was required to increase the yield and enantioselectivity of the reaction.
- This invention relates to a method for the reduction of oxime ethers using these stable spiroborate esters to prepare enantiopure primary arylalkyl amines in a truly catalytic process with excellent enantioselectivity. More specifically, we developed and synthesized stable chiral spiroborate esters derived from enantiopure 1 ,2-aminoalcohols, 5 - 10, shown in Figure 2, as a new type of catalysts for asymmetric reduction of ketones.
- catalyst 5 derived from (S)-diphenylvalinol
- Fig. 1 is a schematic diagram showing a catalytic reduction according to the prior art.
- Fig. 2 is a schematic diagram showing spiroborate esters derived from chiral aminoalcohols according to an embodiment of the invention.
- Fig. 3 is a schematic diagram showing the enantioselective reduction of oxime ethers according to an embodiment of the invention.
- Fig. 4 is a schematic diagram showing the enantioselective reduction of O-benzyl acetophenone oxime with the catalysts according to one embodiment of the invention.
- Fig. 5 is a schematic diagram showing the synthesis of oximes and corresponding O- benzylated arylketoximes according to an embodiment of the invention.
- Fig. 6 is a schematic diagram showing the synthesis and enantioselective reduction of O-benzyl pyridyl ketoximes 13 with a catalyst according to a preferred embodiment of the invention.
- oxazaborolidines for the enantioselective reduction of ketones, oximes and imino derivatives in the preparation of pharmaceutical intermediaries are widely known.
- the present invention is industrially advantageous since it offers a new process for a more efficient and facile preparation of enantiopure amines by reduction with borane in the presence of our recent developed spiroborate esters, which are highly efficient chiral transfer catalysts, analogous to the well-known oxazaborolidines catalysts.
- This process can be used to carry out the preparation of enantiopure drugs with equal or better stereoselectivity in a practical catalytic way.
- the disclosed invention can be applied to the synthesis of (S)-dolaphenine (as disclosed in U.S. Patent No. 6,020,495), a precursor for the preparation of the antineoplastic peptide chain Dolastatin 10, by the borane reduction of 4-CF 3 Bn oxime ether using as reagent the spiroborate ester derived from valinol and ethylene glycol.
- (S)-dolaphenine as disclosed in U.S. Patent No. 6,020,495
- the above-mentioned patent mentions other examples of important chiral amines with pharmaceutical properties that can be prepared by the proposed process using the discovered catalysts, such as the 3-phenyl-1 -indanamines that have antidepressant activity (as disclosed by Bogeso, K. P.
- catalysts 5 - 10 provided quantitatively primary amine 3, which by GC analysis of the ethoxycarbonyl derivative 4 on a chiral column exhibited moderate to high enantioselectivity, catalyst 5 being the most efficient, since it provided 93% ee of ⁇ -methylbenzylamine 3, as illustrated in Table 1.
- the reaction was performed at room temperature in THF using different equivalents of catalyst 5 and borane, and different borane sources like, borane-DMS and borane-THF, with NaBH 4 or ⁇ /-isopropyl ⁇ /-methyl te/t-butyl amine, as additives.
- borane sources like, borane-DMS and borane-THF, with NaBH 4 or ⁇ /-isopropyl ⁇ /-methyl te/t-butyl amine, as additives.
- the ratio of products was determined by GC analysis.
- the ee of compound 3 was determined by chiral GC analysis of the ethoxy carbamide derivative.
- oxime in THF was added in 10 hours, then 24 hours stirring at room temperature.
- the borane reagent was stabilized with ⁇ 0.005 M ⁇ /-isopropyl ⁇ /-methyl te/t-butyl amine.
- the yield in parenthesis was obtained after purification of ethoxy carbamide.
- BH 3 -THF reagent is stabilized with 0.005 M ⁇ /-isopropyl N- methyl te/t-butylamine.
- the amount of borane was 4 equiv to 1 equiv of oxime ether and the reactions were made at room temperature for 36 hours.
- the oxime in the chosen solvent was added during the 1 1 th hour.
- the oxime in the chosen solvent was added during 1 st hour.
- BH 3 -THF reagent is stabilized with 0.005 M ⁇ /-isopropyl ⁇ /-methyl tert- butyl amine.
- BH 3 -THF reagent is stabilized with 0.005 M NaBH 4 .
- a further aspect of the invention involves the effect of aromatic substitution of acetophenone oximes 1 b-e in the enantioselectivity of the reduction shown in Fig. 5. As indicated in Table 6, steric and electronic factors did not change significantly the ee, except for 4-CF 3 benzyl oxime that readily afforded 99% ee.
- the optimized synthetic method was extended to other substrates using unsubstituted O-benzyl oxime ethers since the benzyl bromide not only is less expensive, but also affords pure (£)-benzylated products.
- Representative aromatic benzyl oximes 11 were prepared by the general method, shown in Fig 5, and reduced using 0.1 equiv of catalyst 5 in dioxane at room temperature and 0 0 C. The results are indicated in Table 7. After an acidic work up, the corresponding crude (S) primary amines were acetylated with acetic anhydride in the presence of triethylamine and DMAP in dichloromethane.
- 2-, 3- or 4-pyridyl alkyl oxime ethers were prepared and reduced in the presence of catalyst 5 at different reaction conditions, as indicated in Fig 6 and Table 8.
- the 4-acetylpyridine O-benzyloxime, 13a afforded the N-(1 -pyridyl-4yl-ethyl)-acetamides, 14a, in 99% ee at 0 Q C in dioxane with 5 equiv of BH 3 -THF, but the chemical yield was low, as indicated in entries 4.
- TLC indicated remaining starting material.
- PROCEDURE (F?)-2-amino-1 ,1 ,2-triphenylethanol 1 , (S)-2-amino-1 ,1 ,2-triphenylethanol 1 , (S)-2-amino-3- methyl-1 ,1 -diphenylbutan-1 -ol 2 were synthesized according to literature procedures. These include: (1 ) Bach, J.; Berenger, R.; Garcia, J.; Loscertales, T.; Vilarrasa, J. J. Org. Chem. 1996, 61, 9021 -9025; and (2) Itsuno, S.; Ito, K. J. Org. Chem. 1984, 49, 555-557.
- 1 H, 13 C and 11 B spectra were recorded on a Bruker Avance 400 MHz spectrometer with standard pulse sequences operating at 400.152 MHz, 100.627 MHz, and 128.384 MHz for 1 H, 13 C and 11 B respectively.
- Chiral gas chromatography analysis was processed on a Hewlett Packard GC 5890 equipped with a Chrompack Chiralsil-Dex-CB column (30 m x 0.25 mm ⁇ .25 ⁇ m).
- GC-MS analysis was processed on a Finnigan Trace GC/Polaris Q Mass detector using a Restek RTX-5MS column.
- reaction was quenched with 6N HCI and then 6 N NaOH until the solution was strongly basic.
- the aqueous solution was extracted with diethylether to obtain the primary amine and the combined organic phase was washed with saturated NaCI solution and dried over anhydrous Na 2 SO 4 .
- the solvent was removed under vacuum and the residue acetylated to prepare the amide derivative.
- the reaction mixture was quenched with methanol (5 ml_) and then refluxed for 6 h. The solvent was evaporated under vacuum and the residue was directly acetylated.
- the conversion ratio was determined by GC analysis (Hewlett Packard GC 5890); for compound 1 a: 13.3 min, compound 2a: 12.6 min, and compound 3: 3.9 min. The ratio was calculated from the area accumulation.
- acetic anhydride (0.11 ml_, 1.0 mmol, 2.0 equiv) was added to a solution of the crude amine in anhydrous CH 2 CI 2 (1 OmL) with DMAP (13mg, 10%), Et 3 N (0.2 ml_, 1 mmol, 2.0 equiv). The resulting mixture was stirred for 3 h. The solvent was removed under vacuum. The residue was purified directly by column chromatography on silica gel, eluted with PE/EA (1v/1v) giving the corresponding amides.
- the pyridyl compounds (15a-15h) were purified by column chromatography by elution first with ether, and then with CH 2 CI 2 /CH 3 OH (10v/1 v). The pure amides were analyzed by GC using the chiral column.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrane Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
L'invention concerne une réduction asymétrique d'éther de cétoxime d'arylalkyle et de pyridylalkyle avec du borane catalysé par plusieurs spiroborates chiraux dérivés de 1,2-amino alcools non racémiques. Une conversion complète d'oxime en amine primaire est extrêmement dépendante du catalyseur, de la source et de la quantité de borane et de la température. La conversion et l'énantiosélectivité sont déterminées par la substitution benzylique de l'oxime. Après optimisation, un catalyseur dérivé du diphényl valinol pourrait avec succès permettre d'obtenir des amines primaires avec un bon rendement et une énantiosélectivité s'élevant jusqu'à 99% ee. Au moyen de la méthodologie développée, d'autres pyridyl alkyl méthanamines primaires non racémiques ont également été préparées pour déboucher sur un rendement chimique élevé et une excellente énantiosélectivité.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84114706P | 2006-08-29 | 2006-08-29 | |
| PCT/US2007/076195 WO2008027740A2 (fr) | 2006-08-29 | 2007-08-17 | Synthèse asymétrique catalytique d'amines primaires par réduction au borane d'éthers d'oxime au moyen d'esters de spiroborate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2061748A2 true EP2061748A2 (fr) | 2009-05-27 |
Family
ID=39136714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP07814214A Withdrawn EP2061748A2 (fr) | 2006-08-29 | 2007-08-17 | Synthèse asymétrique catalytique d'amines primaires par réduction au borane d'éthers d'oxime au moyen d'esters de spiroborate |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP2061748A2 (fr) |
| JP (1) | JP2010502632A (fr) |
| CN (1) | CN101547890A (fr) |
| WO (1) | WO2008027740A2 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011329233A1 (en) | 2010-11-15 | 2013-05-23 | Abbvie Deutschland Gmbh & Co Kg | NAMPT and ROCK inhibitors |
| CN102584876A (zh) * | 2012-01-18 | 2012-07-18 | 广西壮族自治区化工研究院 | 高活性手性催化剂螺硼酸酯的制备方法 |
| CN105693595B (zh) * | 2016-04-28 | 2018-09-28 | 上海亚兴生物医药科技有限公司 | 一种(r)-3-氨基-1,2,3,4-四氢咔唑的合成方法 |
| KR102323561B1 (ko) * | 2020-01-06 | 2021-11-09 | (주)분자와물질 | 아미노알콜-보론-바이놀 복합체 및 이를 이용한 광학활성 아미노알콜 유도체의 제조방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2679248B2 (ja) * | 1989-05-26 | 1997-11-19 | 住友化学工業株式会社 | 光学活性アミン類の製造方法 |
| EP0485069B1 (fr) * | 1990-10-08 | 1995-02-15 | Sumitomo Chemical Company Limited | Procédé pour la préparation d'amines optiquement actifs |
| JPH08337556A (ja) * | 1995-04-13 | 1996-12-24 | Sumitomo Chem Co Ltd | 光学活性アミン類の製造法 |
| CN1243757C (zh) * | 2003-02-27 | 2006-03-01 | 武汉大学 | 螯合手性硼酸酯及其制备方法和用途 |
-
2007
- 2007-08-17 EP EP07814214A patent/EP2061748A2/fr not_active Withdrawn
- 2007-08-17 JP JP2009526807A patent/JP2010502632A/ja active Pending
- 2007-08-17 CN CNA2007800402559A patent/CN101547890A/zh active Pending
- 2007-08-17 WO PCT/US2007/076195 patent/WO2008027740A2/fr not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2008027740A2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008027740A3 (fr) | 2008-05-22 |
| CN101547890A (zh) | 2009-09-30 |
| WO2008027740B1 (fr) | 2008-10-16 |
| JP2010502632A (ja) | 2010-01-28 |
| WO2008027740A2 (fr) | 2008-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ferraris et al. | Catalytic, enantioselective alkylation of α-imino esters: The synthesis of nonnatural α-amino acid derivatives | |
| Zhang et al. | Novel chiral P, N-ferrocene ligands in palladium-catalyzed asymmetric allylic alkylations | |
| Byrd | Diastereoselective and enantioselective conjugate addition reactions utilizing α, β-unsaturated amides and lactams | |
| Garner et al. | Selective binding and activation of one aldehyde enantioface by a chiral transition-metal Lewis acid: synthesis, structure, and reactivity of rhenium aldehyde complexes [(. eta. 5-C5H5) Re (NO)(PPh3)(. eta. 2-O: CHR)]+ X | |
| Effenberger et al. | Stereoselective synthesis of thienyl and furyl analogues of ephedrine | |
| CN104447725B (zh) | 一种手性含亚胺吡啶噁唑啉的化合物及其制备方法 | |
| Dieter et al. | Reaction of α-(N-carbamoyl) alkylcuprates with propargyl substrates: synthetic route to α-amino allenes and Δ3-pyrrolines | |
| Wu et al. | Regulation of the flexibility of planar chiral [2.2] paracyclophane ligands and its significant impact on enantioselectivity in asymmetric reactions of diethylzinc with carbonyl compounds | |
| EP2061748A2 (fr) | Synthèse asymétrique catalytique d'amines primaires par réduction au borane d'éthers d'oxime au moyen d'esters de spiroborate | |
| Wu et al. | Novel planar chiral P, N-[2.2] paracyclophane ligands: synthesis and application in palladium-catalyzed allylic alkylation | |
| CN101116828B (zh) | 手性吡啶双噁唑啉催化剂及制备方法和应用 | |
| Chelucci et al. | Chiral 8-amino substituted 2-phenyl-5, 6, 7, 8-tetrahydro-6, 6-dimethylmethanoquinolines as chiral ligands for enantioselective catalysis: palladium catalysed allylic substitution and addition of diethylzinc to benzaldehyde | |
| CN109331872B (zh) | 正丁基锂在催化亚胺和硼烷硼氢化反应中的应用 | |
| He et al. | Synthesis of some new chiral bifunctional o-hydroxyarylphosphonodiamides and their application as ligands in Ti (IV) complex catalyzed asymmetric silylcyanation of aromatic aldehydes | |
| Oh et al. | Self-association free bifunctional thiourea organocatalysts: synthesis of chiral α-amino acids via dynamic kinetic resolution of racemic azlactones | |
| Chen et al. | Enantioselective Strecker-type reaction of phosphinoyl ketimines catalyzed by a chiral Zr-bipyridyldiol catalyst | |
| CN109651445B (zh) | 一种大位阻三价铑亚胺配合物的制备及其应用 | |
| Fukuda et al. | Synthesis of chiral primary 1-ferrocenylalkylamines via highly diastereoselective addition of organolithium compounds to ferrocenecarboxaldehyde imine derived from (S)-2-methoxy-1-phenylethylamine | |
| CN109651160A (zh) | 一种催化苯乙炔氢胺化反应制备烯胺类化合物的方法 | |
| CN101314559B (zh) | 一种芳香族手性仲醇类化合物的制备方法 | |
| Bastin et al. | Chiral ferrocenyl amino alcohols for enantioselective additions of diethylzinc to aldehydes | |
| JP3634207B2 (ja) | 光学活性なα−アミノニトリル並びにα−アミノ酸類の製造方法 | |
| Palomo et al. | On the Question of the Diastereoselective Alkylation of 4-Unsubstituted 3-Amino β-Lactams. A Concise Synthesis of α-Branched α-Amino β-Lactams and their Coupling with α-Amino Acid Esters | |
| Zhao et al. | Bulky alkali metal cations enabled highly efficient iridium-catalyzed asymmetric hydrogenation for C–N axial chirality via dynamic kinetic resolution | |
| Enders et al. | Diastereo-and Enantioselective Syntheses of C2-Symmetric 1, n-Diamines by Nucleophilic Addition to Dialdehyde-SAMP-Hydrazones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20090327 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Effective date: 20101029 |